Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools

Breast Cancer Research and Treatment

Volumn 71, Issue 3, 2002, Pages 237-247

  Chen, Jack S K ^a   Agarwal, Neeraj ^b   Mehta, Kapil ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Apoptosis; Calcium; Multidrug resistance; Thapsigargin; Transglutaminase

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIMYCIN; CALCIUM; DOXORUBICIN; GLYCOPROTEIN P; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIMYCIN; CALCIUM; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FEMALE; GTP-BINDING PROTEINS; HUMANS; IONOPHORES; MICE; MICROSCOPY, CONFOCAL; THAPSIGARGIN; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

EID: 0036202160     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014461832403     Document Type: Article

References (47)

1. Adriamycin. A new anticancer drug with significant clinical activity
2. The human multidrug resistance (mdr1) gene
3. P-glycoproteins and multidrug resistance
4. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines
5. Multidrug resistance: Molecular mechanisms and clinical relevance
6. Mechanisms of multidrug resistance in cancer treatment
7. Topoisomerase I in multiple drug resistance
8. Glutathione and related enzymes in multidrug resistance
9. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha
10. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells
11. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line
12. Transglutaminases: Mmultifunctional cross-linking enzymes that stabilize tissues
13. Tissue transglutaminase: An enzyme with a split personality
14. Detection of epsilon (gamma-glutamyl) lysine
15. Induction and activation of tissue transglutaminase during programmed cell death
16. Transglutaminase induction by various cell death and apoptosis pathways
17. Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes
18. The expression of 'tissue' transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis)
19. 'Tissue' transglutaminase and apoptosis
20. 'Tissue' transglutaminase in cell death: A downstream or a multifunctional upstream effector?
21. Tissue transglutaminase: Apoptosis versus autoimmunity
22. Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: Relationship to development of autoimmunity in MRL/pr/1pr mice
23. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: Effects on the processing of fibronectin, cell attachment, and cell death
24. Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells
25. Expression of tissue transglutaminase in Balb-C3T3 fibroblasts: Effects on cellular morphology and adhesion
26. 2+
27. Development of human leukemia U-937 cell sublines resistant to doxorubicin: Induction of differentiation and altered sensitivities to topoisomerase-directed drugs
28. Assessment of antineoplastic agents by MTT assay: Partial underestimation of antiproliferative properties
29. Assay for redox-sensitive transcription factor
30. Transglutaminases
31. 2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin
32. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases
33. 2+ fit in?
34. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage
35. The role of calcium in the regulation of apoptosis
36. 2+ in toxic cell killing
37. Cell surface actions of Adriamycin
38. Transglutaminase II: A new class of GTP-binding protein with new biological functions
39. Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function
40. Evidence that the Gh protein is a signal mediator from alpha 1-adrenoceptor to a phospholipase C. I. Identification of alpha 1-adrenoceptor-coupled Gh family and purification of Gh7 from bovine heart
41. A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. II. Purification, characterization, and reconstitution
42. Evidence that phospholipase deltal is the effector in the Gh (transglutaminase II)-mediated signaling
43. Evidence that the Gh protein is a signal mediator from alpha 1-adrenoceptor to a phospholipase C. II. Purification and characterization of a Gh-coupled 69-kDa phospholipase C and reconstitution of alpha 1-adrenoceptor, Gh family, and phospholipase C
44. Calcium signalling mechanisms in endoplasmic reticulum activated by inositol 1,4,5-triphosphate and GTP
45. Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action
46. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells